UBE (4208) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Although revenue and operating income increased in the current quarter, the key point is that net income attributable to owners of the parent declined due to a higher tax burden and extraordinary losses. Revenue increased significantly to ¥121.9B (+21.3% YoY), Operating Income to ¥5.55B (+88.6%), and Ordinary Income to ¥11.25B (+81.5%), while Net Income remained virtually flat at ¥4.58B (+0.4%; attributable to owners of the parent was ¥4.19B, down ▲3.9%). The increase in revenue was primarily attributable to the consolidation effect of the high-performance urethane subsidiary and growth in Resins & Chemicals, while the increase in profit resulted from an improved gross margin. However, a sharp increase in the effective tax rate (53.8%) and extraordinary losses of ¥1.51B weighed on final profit.

Factors Affecting Performance

【Revenue】Revenue increased 21.3% YoY to ¥121.9B. By segment, Resins & Chemicals accounted for the largest revenue scale at ¥65.49B (+11.0%), while High-Performance Urethane increased sharply to ¥15.71B (+397.0%), including the consolidation effect of the Urethane Systems business acquired in the previous year. Specialty Products generated ¥20.58B (+18.0%), Machinery ¥14.11B (-2.8%), and Pharmaceuticals ¥4.71B (+9.8%).

【Profit and Loss】Operating Income increased 88.6% YoY to ¥5.55B, and the Operating Margin improved to 4.6% from 2.9% in the previous year period (there is a difference in disclosure values and definitions; this report adopts the XBRL value of 4.6%). The increase in the gross margin to 23.7% exceeded the rise in the SG&A ratio to 19.2%, contributing to higher profit. Ordinary Income increased 81.5% to ¥11.25B, boosted by non-operating income of ¥7.47B, including equity-method investment gain of ¥5.41B and foreign exchange gain of ¥0.97B. Meanwhile, due to extraordinary losses of ¥1.51B and an increase in the effective tax rate to 53.8%, Net Income was ¥4.58B (+0.4%) and Net Income Attributable to Owners of the Parent was ¥4.19B (▲3.9%). In conclusion, the Company recorded higher revenue and profit at the operating and ordinary income levels, but showed the practical characteristics of higher revenue and lower profit at the final profit level due to tax burdens and extraordinary gains and losses.

Segment Analysis

Specialty Products generated revenue of ¥20.58B (+18.0%), Operating Income of ¥3.24B (+69.2%), and a profit margin of 15.7%, making it the segment with the highest profitability company-wide and the largest profit contribution. Resins & Chemicals was the largest segment by revenue at ¥65.49B (+11.0%), but its Operating Income was ¥2.65B (+114.7%) and its profit margin was relatively low at 4.0%. High-Performance Urethane generated revenue of ¥15.71B (+397.0%) and Operating Income of ¥0.61B, turning profitable from a loss of ¥0.44B in the previous year period; however, most of the revenue increase resulted from the acquisition effect. Pharmaceuticals continued to report an Operating Loss of ¥0.50B despite revenue of ¥4.71B (+9.8%), making it the only loss-making segment with a profit margin of ▲10.5%. Machinery remained stable, with revenue of ¥14.11B (▲2.8%), Operating Income of ¥1.09B (+2.9%), and a profit margin of 7.7%. Profit margins differ substantially among segments, indicating a profit structure highly dependent on Specialty Products.

Key Financial Metrics

【Profitability】The Operating Margin was 4.6%, the gross margin was 23.7%, and the Net Profit Margin was approximately 3.4%–3.8%; despite the increase in profit, absolute levels remain on a path toward improvement.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥22.56B, approximately 5.4 times Net Income Attributable to Owners of the Parent of ¥4.19B, indicating strong cash generation relative to accounting profit. Meanwhile, inventories increased by ¥6.09B, and inventory accumulation placed pressure on working capital.【Investment Efficiency】ROE (Annualized) was 4.0% and the Equity Ratio was 48.6%. Asset efficiency was supported by an improvement in the total asset turnover ratio, but challenges remain in monetizing invested capital.【Financial Soundness】The Equity Ratio was 48.6%, and current assets of ¥321.77B exceeded current liabilities of ¥200.89B, indicating stable short-term liquidity. Short-term borrowings decreased approximately 27% from ¥80.75B in the previous year to ¥58.84B, reducing reliance on short-term funding.

Cash Flow Analysis

Operating Cash Flow was ¥22.56B, up 8.1% YoY, demonstrating cash generation substantially exceeding Net Income Attributable to Owners of the Parent of ¥4.19B. A decrease in trade receivables (+¥6.06B) and an increase in trade payables (+¥9.25B) supported OCF, while inventories increased by ¥6.09B, and inventory accumulation associated with revenue growth consumed part of the cash. Investing Cash Flow was an inflow of ¥13.17B; despite capital expenditures for the acquisition of property, plant and equipment and other assets of ¥16.75B, the overall balance was a cash inflow due to proceeds from the sale of investment securities and other items. Financing Cash Flow was ▲¥26.69B, reflecting cash outflows from the reduction of short-term borrowings and dividend payments of ¥5.35B, among other factors. Free Cash Flow (OCF + Investing Cash Flow) was ¥35.73B, and cash and cash equivalents increased by ¥9.69B during the current quarter.

Quality of Earnings

Of Ordinary Income of ¥11.25B, non-operating income of ¥7.47B, including equity-method investment gain of ¥5.41B and foreign exchange gain of ¥0.97B, made a substantial contribution and exceeded the core Operating Income of ¥5.55B. This point requires attention when assessing earnings quality. Extraordinary income was ¥0.18B against extraordinary losses of ¥1.51B, resulting in a difference of ¥1.33B that acted as a temporary factor depressing Net Income. In addition, the effective tax rate rose sharply from the previous year period to 53.8% (income taxes of ¥5.34B / Profit Before Tax of ¥9.92B), and the improvements at the operating and ordinary income levels were not fully reflected in final profit. The fact that OCF substantially exceeded Net Income indicates good accrual quality; however, the Company has a high degree of dependence on non-operating factors, including equity-method investment gains, foreign exchange gains, and tax burdens, which will require monitoring as potential drivers of future volatility.

Earnings Forecast and Guidance

The Full-Year forecast remains unchanged in the current quarter, with Revenue of ¥485.0B (+4.9% YoY), Operating Income of ¥23.50B (+24.1%), and Ordinary Income of ¥37.50B (±0.0%). Revenue progress was approximately 25.1%, consistent with the standard 25% level, while Operating Income progress was approximately 23.6%, slightly below that level. Ordinary Income progress was approximately 30.0%, exceeding the standard level, although the contribution of non-operating factors such as equity-method investment gains and foreign exchange gains was significant. Progress toward Full-Year Net Income Attributable to Owners of the Parent of ¥24.50B was approximately 17.1%, below the standard 25% level, and the high tax burden and extraordinary losses incurred in the current quarter are challenges to achieving the Full-Year target.

Shareholder Returns

The Full-Year dividend forecast remains unchanged at ¥160.00 per share. Based on the Full-Year forecast EPS of ¥252.20, the forecast Payout Ratio is approximately 63.4%, slightly above the benchmark of 60%. Dividend payments during the current quarter were ¥5.35B, while share repurchases were virtually not conducted (¥0.0B), making dividends the primary form of shareholder returns. OCF of ¥22.56B was approximately 4.2 times dividend payments, ensuring the Company’s near-term ability to continue paying dividends from a cash flow perspective. However, given the Payout Ratio, the achievement of Full-Year Net Income will be an important factor in assessing sustainability.

Risk Factors

1. Profitability and capital efficiency challenges: Although the Operating Margin of 4.6% improved from the previous year, it remains low even compared with the industry median. In addition, the increase in the effective tax rate to 53.8% prevented the improvements at the operating and ordinary income levels from being fully converted into final profit.

2. Inventory and working capital risk: Inventories increased by ¥6.09B during the current quarter, and inventory accumulation in response to revenue growth consumed some cash. Although OCF was strong due to improvements in trade receivables and trade payables, trends in inventory efficiency could affect the sustainability of cash generation.

3. Continued losses in the Pharmaceuticals segment and integration risk for the acquired segment: Pharmaceuticals continued to report an Operating Loss of ¥0.50B despite higher revenue. High-Performance Urethane turned profitable, but much of its substantial revenue growth resulted from the consolidation effect of the subsidiary acquired in the previous year; confirming the sustainability of synergies remains a future challenge.

Industry Benchmark (Reference; Company Analysis)

Profitability and Return

Both the Operating Margin and Net Profit Margin were below the industry median, placing the Company’s earnings power in the lower tier of the industry.

Growth and Capital Efficiency

The Revenue Growth Rate substantially exceeded the industry median, placing the Company in the upper tier of the industry in terms of growth.

※Source: Company analysis

Key Points from the Earnings Results

1. Although the Operating Margin improved from the previous year, Ordinary Income has a high degree of dependence on non-operating factors such as equity-method investment gains and foreign exchange gains, and the core earnings power of the business itself remains relatively low within the industry.

2. Net Income Attributable to Owners of the Parent declined 3.9% YoY, moving in a different direction from the substantial increases in operating and ordinary income. This resulted from the higher effective tax rate and recognition of extraordinary losses, and was one reason that the Full-Year progress rate of approximately 17.1% was below the standard level.

3. The high profit margin of the Specialty Products segment (15.7%) and the return to profitability of High-Performance Urethane indicate qualitative improvement in the portfolio. At the same time, the low profit margin of Resins & Chemicals (4.0%) and continued losses in Pharmaceuticals demonstrate that differences in profitability among segments are a driver of fluctuations in company-wide profit.

Theoretical Share Price (Reference Value)

Sensitivity: ¥4,206–¥4,444 at Cost of Equity ±1%, and ¥4,310–¥4,330 at ω±0.1.

Notes:

• Goodwill amortization of ¥24.6/share is added back to profit (to account for a non-cash expense and comparability with IFRS companies).
• Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value per Share.
• Net assets as of the end of the quarter are used (there is a timing difference from the Full-Year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data and is not a forecast of the market share price, a recommendation of any specific investment action, or a prediction or guarantee of future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional adviser as necessary.

---End of Report---